ORIGINAL RESEARCH article

Front. Public Health

Sec. Infectious Diseases: Epidemiology and Prevention

Volume 13 - 2025 | doi: 10.3389/fpubh.2025.1548456

Prepandemic levels of cytokines and immunoglobulins and risk of SARS-CoV-2 infection and COVID-19 in the general population of Barcelona

Provisionally accepted
Miquel  PortaMiquel Porta1*José  PumaregaJosé Pumarega1Ruth  AguilarRuth Aguilar2David  Prieto-MerinoDavid Prieto-Merino3Laura  CampiLaura Campi1Cristina  RiusCristina Rius4Judit  Villar-GarcíaJudit Villar-García1Marta  Vidal CostaMarta Vidal Costa2Alfons  Jimenez MoreraAlfons Jimenez Morera2Antonio  PeñaAntonio Peña3Leonardo  TrasandeLeonardo Trasande5Francisco  BolúmarFrancisco Bolúmar3Gemma  MoncunillGemma Moncunill2Carlota  DobanoCarlota Dobano2Magda  GasullMagda Gasull1
  • 1Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
  • 2Instituto Salud Global Barcelona (ISGlobal), Barcelona, Catalonia, Spain
  • 3University of Alcalá, Alcalá de Henares, Madrid, Spain
  • 4Barcelona Public Health Agency (ASPB), Barcelona, Catalonia, Spain
  • 5New York University, New York City, New York, United States

The final, formatted version of the article will be published soon.

Background: From a public health perspective it is remarkable that there are yet no longitudinal studies in the general population investigating the influence of the basal immune state, measured before the pandemic, on the risk of SARS-CoV-2 infection and COVID-19.Objective: To investigate the specific and combined effects of personal levels of cytokines and immunoglobulins -measured in individuals' blood 4 years before the pandemic-on the risk of SARS-CoV-2 infection and COVID-19 in a general population.: We conducted a prospective cohort study in 240 individuals from the general population of Barcelona. Thirty cytokines and 31 immunoglobulins were quantified in prepandemic serum samples (collected in 2016-17) by high-throughput multiplex quantitative suspension array technology. Results: Higher concentrations in 2016-17 of IL-8 and TNF-α significantly decreased the risk of SARS-CoV-2 seropositivity in 2020-21, whereas higher concentrations of MIP-1α were a risk factor for seropositivity. Most cytokines in mixtures with IL-8, MIP-1α, TNF-α or G-CSF were associated with SARS-CoV-2 seropositivity (all OR ≥2.0 or OR≤0.4 and p<0.05). The five individual isotypeantigen pairs more clearly associated with seropositivity were: protectively, IgG to CMV pp150, IgG to CMV pp65, and IgG to N OC43; and, increasing risk of seropositivity, IgM to CMV pp65 and IgM to EBV EA-D. The four cytokines most consistently associated with the risk of COVID-19 were also G-CSF, IL-8, TNF-α, and MIP-1α. The four isotype-antigen pairs more strongly associated with risk of COVID-19 (all protective) were IgA to CMV pp65 and N 229E, and IgG to EBV EAD and VCAp18.The unique longitudinal design of this study, with measurements before and during the pandemic in a general population, provides novel knowledge on the protective and detrimental effects of specific individual cytokines and immunoglobulins, and their mixtures, on the risk of SARS-CoV-2 seropositivity and COVID-19. If confirmed, findings would be significantly relevant for medicine and public health.

Keywords: BHS, Barcelona Health Survey, BMI, body mass index, CI, confidence interval, CMV, cytomegalovirus, COVID-19, coronavirus disease 2019, EBV, Epstein-Barr virus, EGF, epidermal growth factor, FGF, fibroblast growth factor

Received: 19 Dec 2024; Accepted: 24 Jun 2025.

Copyright: © 2025 Porta, Pumarega, Aguilar, Prieto-Merino, Campi, Rius, Villar-García, Vidal Costa, Jimenez Morera, Peña, Trasande, Bolúmar, Moncunill, Dobano and Gasull. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Miquel Porta, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.